References
- Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020 May;70(3):145–164.
- Available from: https://gco.iarc.fr/today/online-analysis-multi-bars?v=2020&mode=cancer&mode_population=countries&population=900&populations=900&key=total&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=1&include_nmsc_other=1&type_multiple=%257B%2522inc%2522%253Afalse%252C%2522mort%2522%253Atrue%252C%2522prev%2522%253Afalse%257D&orientation=horizontal&type_sort=0&type_nb_items=%257B%2522top%2522%253Atrue%252C%2522bottom%2522%253Afalse%257D 25 6 2021
- Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019 Oct 19;394(10207):1467–1480.
- Georgiou A, Khakoo S, Edwards P, et al. Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer Center. Cancers (Basel). 2019 Oct 14;11(10):1558.
- Cao M, Li H, Sun D, et al. Cancer burden of major cancers in China: a need for sustainable actions. Cancer Commun (Lond). 2020 May;40(5):205–210.
- Simard J, Kamath S, Kircher S. Survivorship Guidance for Patients with Colorectal Cancer. Curr Treat Options Oncol. 2019 Apr 1;20(5):38.
- Lugli A, Zlobec I. The battle for prognosis at the invasive front of colorectal cancer. EBioMedicine. 2020 Aug;58:102918.
- Zheng C, Jiang F, Lin H, et al. Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study. Clin Transl Oncol. 2019 Nov;21(11):1524–1531.
- Mahar AL, Compton C, Halabi S, et al. Personalizing prognosis in colorectal cancer: a systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol. 2017 Dec;116(8):969–982.
- Lin C, Yang L. Long Noncoding RNA in Cancer: wiring Signaling Circuitry. Trends Cell Biol. 2018 Apr;28(4):287–301.
- Akhade VS, Pal D, Kanduri C. Long Noncoding RNA: genome Organization and Mechanism of Action. Adv Exp Med Biol. 2017;1008:47–74.
- Lorenzi L, Avila Cobos F, Decock A, et al. Long noncoding RNA expression profiling in cancer: challenges and opportunities. Genes Chromosomes Cancer. 2019 Apr;58(4):191–199.
- Huyghe JR, Bien SA, Harrison TA, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019 Jan;51(1):76–87.
- Huang X, Zhang W, Shao Z. Association between long non-coding RNA polymorphisms and cancer risk: a meta-analysis. Biosci Rep. 2018 Aug 31;38(4). DOI:10.1042/BSR20180365.
- Fernandes JCR, Acuña SM, Aoki JI, et al. Long Non-Coding RNAs in the Regulation of Gene Expression: physiology and Disease. Noncoding RNA. 2019 Feb 17;5(1):17.
- Deng H, Wang JM, Li M, et al. Long non-coding RNAs: new biomarkers for prognosis and diagnosis of colon cancer. Tumour Biol. 2017 Jun;39(6):1010428317706332.
- Xu J, Zhang P, Sun H, et al. LINC01094/miR-577 axis regulates the progression of ovarian cancer. J Ovarian Res. 2020 Oct 17;13(1):122.
- Zhu B, Liu W, Liu H, et al. LINC01094 Down-Regulates miR-330-3p and Enhances the Expression of MSI1 to Promote the Progression of Glioma. Cancer Manag Res. 2020;12:6511–6521.
- Xu H, Wang X, Wu J, et al. Long Non-coding RNA LINC01094 Promotes the Development of Clear Cell Renal Cell Carcinoma by Upregulating SLC2A3 via MicroRNA-184. Front Genet. 2020;11:562967.
- Yang C, Pan Y, Deng SP. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells. BMC Mol Cell Biol. 2019 Apr 23;20(1):9.
- Wang Z, Zhao Z, Yang Y, et al. MiR-99b-5p and miR-203a-3p Function as Tumor Suppressors by Targeting IGF-1R in Gastric Cancer. Sci Rep. 2018 Jul 4;8(1):10119.
- Wang S, Li P, Jiang G, et al. Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal. Bioengineered. 2020 Dec;11(1):718–728.
- Zhao X, Wu J, Li Y, et al. Long non-coding RNA FENDRR inhibits the stemenss of colorectal cancer cells through directly binding to Sox2 RNA. Bioengineered. 2021 Dec;12(1):8698–8708.
- Jiang Y, Li W, Yan Y, et al. LINC01094 triggers radio-resistance in clear cell renal cell carcinoma via miR-577/CHEK2/FOXM1 axis. Cancer Cell Int. 2020;20(1):274.
- Zhang H, Liu S, Tang L, et al. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9). Bioengineered. 2021 Dec;12(1):162–171.
- Wang J, Liu Y, Cai H, et al. Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p/CREB1 axis. Bioengineered. 2021 Dec;12(1):6264–6274.
- O’Brien SJ, Fiechter C, Burton J, et al. Long non-coding RNA ZFAS1 is a major regulator of epithelial-mesenchymal transition through miR-200/ZEB1/E-cadherin, vimentin signaling in colon adenocarcinoma. Cell Death Discov. 2021 Mar 26;7(1):61.
- Moore J, Uchida S. Functional characterization of long noncoding RNAs. Curr Opin Cardiol. 2020 May;35(3):199–206.
- Wei Z, Liu G, Jia R, et al. Targeting secretory leukocyte protease inhibitor (SLPI) inhibits colorectal cancer cell growth, migration and invasion via downregulation of AKT. PeerJ. 2020;8:e9400.
- Nugteren S, Goos J, Delis-van Diemen PM, et al. Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis. Oncoimmunology. 2020 Oct 13;9(1):1832761.
- Yu G, Xiong D, Liu Z, et al. Long noncoding RNA LINC00052 inhibits colorectal cancer metastasis by sponging microRNA-574-5p to modulate CALCOCO1 expression. J Cell Biochem. 2019 Oct;120(10):17258–17272.
- Rivandi M, Pasdar A, Hamzezadeh L, et al. The prognostic and therapeutic values of long noncoding RNA PANDAR in colorectal cancer. J Cell Physiol. 2019 Feb;234(2):1230–1236.
- Lu X, Liu Z, Ning X, et al. The Long Noncoding RNA HOTAIR Promotes Colorectal Cancer Progression by Sponging miR-197. Oncol Res. 2018 Apr 10;26(3):473–481.
- Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017 Oct 12;36(41):5661–5667.
- Li J, Meng H, Bai Y, et al. Regulation of lncRNA and Its Role in Cancer Metastasis. Oncol Res. 2016;23(5):205–217.
- Dhamija S, Diederichs S. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis. Int J Cancer. 2016 Jul 15;139(2):269–280.
- Huang L, Dai G. Long non-coding RNA DCST1-AS1/hsa-miR-582-5p/HMGB1 axis regulates colorectal cancer progression. Bioengineered. 2022 Jan;13(1):12–26.
- Li YQ XX. Linc01094 Accelerates the Growth and Metastatic-Related Traits of Glioblastoma by Sponging miR-126-5p. Onco Targets Ther. 2020;13:9917–9928.
- Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–286.
- Zhao Z, Sun W, Guo Z, et al. Mechanisms of lncRNA/microRNA interactions in angiogenesis. Life Sci. 2020 Aug 1;254:116900.
- Wu X, Kong C, Wu Y. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis. Bioengineered. 2021 Dec;12(1):9046–9057.